Carcinosarcoma of the uterus: A clinicopathological multicenter CTF study

Enrico Sartori, Luca Bazzurini, Angiolo Gadducci, Fabio Landoni, Andrea Lissoni, Tiziano Maggino, Paolo Zola, Beniamino La Face

Research output: Contribution to journalArticlepeer-review


The purpose of this paper is to retrospectively analyze the clinical and pathological data of 118 cases of uterine carcinosarcoma. Prognostic factors and management were evaluated. χ2 and log-rank tests were performed. Surgical stage at time of surgery was the most important prognostic factor (P <0.0001); in stage I-II disease depth of myometrial invasion and lymphatic/vascular space involvement were significantly related to outcome, whereas other factors were not useful. In stage I-II patients postoperative radiation did not improve 5-year disease-free survival. Survival curves in patients with advanced disease treated with cisplatin-containing regimens or with doxorubicin (without cisplatin)-containing regimens were overlapping.

Original languageEnglish
Pages (from-to)70-75
Number of pages6
JournalGynecologic Oncology
Issue number1
Publication statusPublished - Oct 1997

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology


Dive into the research topics of 'Carcinosarcoma of the uterus: A clinicopathological multicenter CTF study'. Together they form a unique fingerprint.

Cite this